By Digifin Pty Ltd · About this coverage

About Pro Medicus (ASX:PME)
Pro Medicus Limited is an ASX-listed healthcare imaging software company headquartered in Melbourne. It develops and licenses medical imaging software, including the Visage 7 enterprise imaging platform sold through its United States subsidiary Visage Imaging, alongside radiology information system products. Its customers are hospitals, academic medical centres and diagnostic imaging providers, principally in the United States, with further operations in Australia and Europe.
Pro Medicus Limited (ASX:PME) announced that its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a 7-year, A$23 million contract with St. Luke's Health System, based in Boise, Idaho. The contract is for Visage 7 Viewer and Visage 7 Workflow, with the Visage 7 Enterprise Imaging Platform to be implemented in the cloud throughout St. Luke's to provide a single, unified enterprise imaging platform. Pro Medicus said the contract is based on a transactional licensing model with potential upside, and that the contract spans three states. Planning for the rollout is to commence immediately and will be based on Visage's cloud-based implementation process, with go-live targeted for Q1 in the 2027 calendar year.
The company described St. Luke's as Idaho's largest private employer and not-for-profit healthcare provider, with St. Luke's Boise Medical Center the flagship hospital of a system spanning 10 medical centers, including St. Luke's Children's Hospital. Pro Medicus Chief Executive Officer Dr Sam Hupert said St. Luke's provides community-based care to patients across southern Idaho, eastern Oregon and northern Nevada, and that it joins a growing list of Visage 7 clients opting for the fully cloud-based platform, which he said is becoming the standard in the North American healthcare IT market as a result of the company's CloudPACS strategy. Dr Hupert also said the company's pipeline remains strong and spans all market segments, from tier 1 academic medical centres through to large and mid-sized integrated delivery networks and private imaging groups.
Source: Pro Medicus Limited (ASX:PME), 12 August 2026. Summary content supplied by Digifin Pty Ltd.
News summary only, not financial advice. It does not consider your objectives, financial situation or needs.




